APA (7th ed.) Citation

MRÁZ, M., LACINOVÁ, Z., KAVÁLKOVÁ, P., HALUZÍKOVÁ, D., TRACHTA, P., DRÁPALOVÁ, J., . . . HALUZÍK, M. (2011). Serum Concentrations of Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: The Influence of Acute Hyperinsulinemia, Very-Low Calorie Diet and PPAR-α Agonist Treatment. Physiological research, 60(4), 627-636. https://doi.org/10.33549/physiolres.932099

Chicago Style (17th ed.) Citation

MRÁZ, M., Z. LACINOVÁ, P. KAVÁLKOVÁ, D. HALUZÍKOVÁ, P. TRACHTA, J. DRÁPALOVÁ, V. HANUŠOVÁ, and M. HALUZÍK. "Serum Concentrations of Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: The Influence of Acute Hyperinsulinemia, Very-Low Calorie Diet and PPAR-α Agonist Treatment." Physiological Research 60, no. 4 (2011): 627-636. https://doi.org/10.33549/physiolres.932099.

MLA (9th ed.) Citation

MRÁZ, M., et al. "Serum Concentrations of Fibroblast Growth Factor 19 in Patients With Obesity and Type 2 Diabetes Mellitus: The Influence of Acute Hyperinsulinemia, Very-Low Calorie Diet and PPAR-α Agonist Treatment." Physiological Research, vol. 60, no. 4, 2011, pp. 627-636, https://doi.org/10.33549/physiolres.932099.